Chapter 9.3 Flashcards
Define hemorrhage and thrombogenesis
Thrombosis: excessive clotting
Hemorrhage: inadequate clotting
- State the sequence of events in the intrinsic system of clotting using the following terms: clotting factor XII, damaged vessel (collagen), clotting factor X, prothrombin, thrombin, fibrinogen, fibrin, and clot.
- State the sequence of events in the extrinsic system of clotting using the following terms: clotting factor VII, tissue factor (thromboplastin), clotting factor X, prothrombin, thrombin, fibrinogen, fibrin, and clot.
- State the sequence of events in the breakdown of a clot using the terms: tissue plasminogen activator (tPA), plasminogen, plasmin, and clot.
These sequences are better explained through the slides
State the primary use for anticoagulants.
used in venous thrombosis
heparin mechanism of action (MOA)
Heparin acts by increasing effects of antithrombin III
enoxaparin (MOA)
is a low molecular weight heparins and it inhibits factor X
warfarin (MOA)
inhibit vitamin K function in liver and decrease synthesis of certain clotting factors
dabigatran (MOA)
direct thrombin inhibitors
Apixaban (MOA)
factor X inhibitors
List the differences between unfractionated heparin and low molecular weight heparins.
administration is different. Unfractionated heparin needs several injections which can lead to side effects. Whereas LMWH is once a day. LMWH is safer and their mechanisms are different
Define and distinguish type I and type II heparin-induced thrombocytopenia (HIT).
Type 1 HIT: asymptomatic and resolves spontaneously
Type 2 HIT: immune reaction and caused thrombosis that is life threatening
List common food sources of vitamin K.
cabbage, cauliflower, spinach, milk and other green veggies
State the relationship between warfarin anticoagulation effects and the dietary intake of vitamin K.
don’t dramatically increase vitamin K intake when taking warfarin
Aspirin (MOA)
inhibits PG and thromboxane biosynthesis by blocking cyclooxygenase enzyme
clopidogrel (MOA)
block effects of ADP on platelet
Abciximab (MOA)
block effects of fibrinogen and other activators on platelet
State the role of thromboxane on platelet function.
increase platelet activity/aggregation